Angelini and Arvelle create neurology player with $960m mergerThere’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Share XAngelini and Arvelle create neurology player with $960m mergerhttps://pharmaphorum.com/news/angelini-and-arvelle-create-neurology-player-with-960m-merger/